Dermawerx Surgical Plus Pak

Product NDC: 69329-270
11-digit product format: 693290270
Labeler code: 69329
Product ID: 69329-270_268023e4-43f1-3d4c-e054-00144ff8d46c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Mupirocin Ointment Kit
Dosage form: KIT
Route: TOPICAL
Labeler: Patchwerx Labs, Inc.
Application: ANDA065123
Marketing category: ANDA
Marketing start: 2015-10-21
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	69329-270		I	Inactivated by FDA		2026-08-17
excluded package	package	69329-270	69329-270-01	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69329-270-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69329-270-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69329-270-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69329-270-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69329-270-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69329-270-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69329-270-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69329-270-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69329-270-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69329-270-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69329-270-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69329-270-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69329-270-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69329-270-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69329-270-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	69329-270-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	69329-270-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	69329-270-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	69329-270-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	69329-270-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	69329-270-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	69329-270-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065123-001	MUPIROCIN	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065123-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065123-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065123-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065123-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065123-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065123-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065123-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065123-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065123-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065123-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065123-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065123-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065123-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065123-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065123-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065123-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065123-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065123-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065123-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065123-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065123-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065123-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065123-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065123-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065123-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065123-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065123-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065123-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065123-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065123-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065123-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065123-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065123-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065123-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065123-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065123-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065123-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065123-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065123-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065123-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065123-001	AB	1	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f2f8c312-f164-6104-0de4-ec45484840e3	Product name	2	20260304
59361619-24d9-b610-eca6-5a7f25ed5e03	Product name	5	20240909
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
0c2e0212-b823-4ce8-611e-853ac2cac1b2	Product name	4	20230327
5e18e798-5614-cf5c-0185-38b1cb77a093	Product name	2	20160822
bb6d6c68-649d-4e6d-a1f6-603d969c8f68	Product name	1	20160303
3db2f5c1-f78c-f062-515c-4827e36c2518	Product name	1	20140508
f74f326b-f453-01a0-e7e7-ce5ea9475503	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69329-270-01	2020-01-31	C162847	48780-1	9d75b9d0-2647-f424-e053-dadaa90a57ce	Dermawerx Surgical Plus Pak

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0116-1061-08	Dermawerx Surgical Plus Pak	237 mL in 1 BOTTLE, PLASTIC	SOLUTION	237 mL	4 g in 100mL	1
45802-112-22	Dermawerx Surgical Plus Pak	22 g in 1 TUBE	OINTMENT	22 g	20 mg in 1g	1
69329-253-02	Dermawerx Surgical Plus Pak	118 mL in 1 TUBE	CREAM	118 mL	50 mg in 1mL	1
69329-270-01	Dermawerx Surgical Plus Pak	1 in 1 KIT	KIT	1		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69329-270-01	EA - Each	69329-270	f7bfaab2-b871-46b5-97da-6fabaafa4186	1	2016-01-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69329-270	DERMAWERX SURGICAL PLUS PAK (MUPIROCIN OINTMENT KIT) KIT [PATCHWERX LABS, INC.]	1	Legacy NDC, 4 package rows	20151210_268023e4-43f0-3d4c-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
mupirocin	MUPIROCIN	Preferred Pharmaceuticals Inc.	6c9cd7fc-b72e-406e-b9aa-0f1bc035b832	2026-07-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	HAWAII REPACK, INC.	7eaa296c-3f98-4f11-b4c1-62c2bc22a9a1	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	St. Mary's Medical Park Pharmacy	235c4f77-e751-a69f-e063-6394a90a1f96	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	REMEDYREPACK INC.	290b4e51-59b4-429a-987b-715ac817ef2c	2026-01-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	6cef3abf-9f17-459e-86b9-95896d9620b7	2025-10-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	7e7675fb-4bfa-46ac-ac1b-0918593d63ee	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	ATLANTIC BIOLOGICALS CORP.	da2f7d4e-82c6-4790-8eea-3a97e5b30734	2025-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
Mupirocin	MUPIROCIN OINTMENT	Kesin Pharma Corporation	b8e115ce-c8ff-4d08-b865-71dc4d0e51a1	2025-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	NuCare Pharmaceuticals,Inc.	831060e6-17ef-b0a0-e053-2991aa0aeb4f	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	A-S Medication Solutions	a6c22c25-0f02-4c06-bbc2-723a18ecdda8	2024-01-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Padagis Israel Pharmaceuticals Ltd	e9b61f01-3c67-42a4-a62b-10f1d1343190	2023-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	1cd4c71f-138b-47c2-8ce8-9ac32408dc56	2023-07-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Proficient Rx LP	97f8d67d-c422-4a26-9394-24a5ec9719d9	2022-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Asclemed USA, Inc.	b2ff9c56-ca19-48ca-bd08-4b33edb13a08	2020-11-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
211365	chlorhexidine gluconate 4 % Medicated Liquid Soap	PSN	268023e4-43f0-3d4c-e054-00144ff8d46c	1
259090	dimethicone 5 % Topical Cream	PSN	268023e4-43f0-3d4c-e054-00144ff8d46c	1
106346	mupirocin 2 % Topical Ointment	PSN	268023e4-43f0-3d4c-e054-00144ff8d46c	1
211365	chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap	SCD	268023e4-43f0-3d4c-e054-00144ff8d46c	1
259090	dimethicone 50 MG/ML Topical Cream	SCD	268023e4-43f0-3d4c-e054-00144ff8d46c	1
106346	mupirocin 0.02 MG/MG Topical Ointment	SCD	268023e4-43f0-3d4c-e054-00144ff8d46c	1
211365	chlorhexidine gluconate 4 % Medicated Liquid Soap	SY	268023e4-43f0-3d4c-e054-00144ff8d46c	1
211365	chlorhexidine gluconate 4 % Medicated Surgical Scrub	SY	268023e4-43f0-3d4c-e054-00144ff8d46c	1
259090	dimethicone 5 % Topical Cream	SY	268023e4-43f0-3d4c-e054-00144ff8d46c	1
106346	mupirocin 2 % Topical Ointment	SY	268023e4-43f0-3d4c-e054-00144ff8d46c	1
106346	mupirocin 20 MG per GM Topical Ointment	SY	268023e4-43f0-3d4c-e054-00144ff8d46c	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
0116-1061-08	00116106108	237 mL in 1 BOTTLE, PLASTIC	237 ml	Historical
45802-112-22	45802011222	22 g in 1 TUBE	22 g	Historical
69329-253-02	69329025302	118 mL in 1 TUBE	118 ml	Historical
69329-270-01	69329027001	1 in 1 KIT		Historical